Study Title: A prospective, observational, single-arm, open-label, single-center study to evaluate the feasibility and performance of the MIZZO ENDO 4000 Robotic System in real world settings.

Study Device: Mizzo Endo 4000 Advanced Surgical Robotic System

Objective: To evaluate the feasibility and performance of MIZZO ENDO 4000.

Study Design: A prospective, observational, single-arm, open-label, single-center study.

Rationale of the Study: Minimally invasive surgery (MIS) has become the standard of care across various surgical specialties due to reduced postoperative pain, shorter hospital stays, and quicker recovery times. Robotic-assisted surgery enhances MIS by offering improved dexterity, precision, and visualization. The MIZZO Endo 4000 Advanced Surgical Robotic System is a next-generation platform designed to optimize surgical performance through advanced ergonomics, multi-arm coordination, and high-definition 3D imaging. However, clinical data evaluating its safety, feasibility, and surgical outcomes across different specialties remain limited. This study aims to assess the intraoperative performance, postoperative recovery, and overall surgical success rates using the MIZZO Endo 4000 in lower gastrointestinal, gynecological, and urological procedures. Key parameters include operative time, console time, blood loss, complication rates, and surgeon satisfaction. By capturing both objective surgical metrics and subjective feedback, the study intends to provide a comprehensive evaluation of the system’s effectiveness. The inclusion of a long-term follow-up phase will also help assess sustained outcomes and potential late complications. The findings will contribute essential clinical evidence to support the broader adoption of the MIZZO Endo 4000 in routine surgical practice.